Independent Labs, Institutes, and Centers (Dean of Research)


Showing 121-130 of 553 Results

  • Alfredo Dubra, PhD

    Alfredo Dubra, PhD

    Professor of Ophthalmology

    Current Research and Scholarly InterestsOur lab seeks to help the early diagnosing and monitoring progression of ocular, vascular, neurodegenerative and systemic diseases through novel non-invasive optical ophthalmic imaging. We pursue this goal through a multidisciplinary approach that integrates optics, computer science, vision science, electrical engineering and other engineering disciplines.

  • Laramie Duncan

    Laramie Duncan

    Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)

    Current Research and Scholarly InterestsWe study genetic and environmental effects on mental health. Much of our work is computational and it relies upon genetic data, collected from millions of individuals, from around the world. We use genetic approaches because the overall goal of the lab is to discover fundamental information about psychiatric disorders, and ultimately to build more rational approaches to classification, prevention, and treatment.

  • Alexander Dunn

    Alexander Dunn

    Professor of Chemical Engineering

    Current Research and Scholarly InterestsMy lab is deeply interested in uncovering the physical principles that underlie the construction of complex, multicellular animal life.

  • James Dunn

    James Dunn

    Professor of Surgery (Pediatric Surgery) and, by courtesy, of Bioengineering

    Current Research and Scholarly InterestsIntestinal lengthening for short bowel syndrome
    Intestinal stem cell therapy for intestinal failure
    Skin derived precursor cell therapy for enteric neuromuscular dysfunction
    Intestinal tissue engineering

  • Emmanuel During, MD

    Emmanuel During, MD

    Clinical Associate Professor, Neurology & Neurological Sciences

    Current Research and Scholarly InterestsImproving diagnostics and therapeutics in RBD, using home ambulatory devices including wearable actigraphy, dry-EEG, to power clinical trials based on objective outcomes of RBD activity.

    Controlling symptoms of RBD testing drugs rigorously.

    Predicting the course of neurodegeneration using deep phenotyping using clinical and serum biomarkers, measures of autonomic impairment, skin biopsy, microbiome

  • Shirit Einav

    Shirit Einav

    Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology

    Current Research and Scholarly InterestsOur basic research program focuses on understanding the roles of virus-host interactions in viral infection and disease pathogenesis via molecular and systems virology single cell approaches. This program is combined with translational efforts to apply this knowledge for the development of broad-spectrum host-centered antiviral approaches to combat emerging viral infections, including dengue, coronaviruses, encephalitic alphaviruses, and Ebola, and means to predict progression to severe disease.

  • Abbas El Gamal

    Abbas El Gamal

    Hitachi America Professor in the School of Engineering

    BioAbbas El Gamal is the Hitachi America Professor in the School of Engineering and Professor in the Department of Electrical Engineering at Stanford University. He received his B.Sc. Honors degree from Cairo University in 1972, and his M.S. in Statistics and Ph.D. in Electrical Engineering both from Stanford University in 1977 and 1978, respectively. From 1978 to 1980, he was an Assistant Professor of Electrical Engineering at USC. From 2003 to 2012, he was the Director of the Information Systems Laboratory at Stanford University. From 2012 to 2017 he was Chair of the Department of Electrical Engineering at Stanford University. His research contributions have been in network information theory, FPGAs, and digital imaging devices and systems. He has authored or coauthored over 230 papers and holds 35 patents in these areas. He is coauthor of the book Network Information Theory (Cambridge Press 2011). He has received several honors and awards for his research contributions, including the 2016 Richard W. Hamming Medal, the 2012 Claude E. Shannon Award, and the 2004 INFOCOM Paper Award. He is a member of the U.S. National Academy of Engineering and a Fellow of the IEEE. He has co-founded and served on the board of directors and advisory boards of several semiconductor and biotechnology startup companies.

  • Edgar Engleman

    Edgar Engleman

    Professor of Pathology and of Medicine (Immunology and Rheumatology)

    Current Research and Scholarly InterestsDendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

  • Neir Eshel, MD, PhD

    Neir Eshel, MD, PhD

    Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)

    BioDr. Eshel (he/him/his) is a tenure-track Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.

    His clinical focus is the full-spectrum mental health care of sexual and gender minorities, with particular interest in depression, anxiety, and the complex effects of trauma in this population. He works in collaboration with other primary care and mental health providers at the Stanford LGBTQ+ program.

    His research interests (www.staarlab.com) include the use of optogenetic, electrophysiological, neuroimaging, and behavioral approaches to probe the neural circuits of reward processing, decision making, and social behavior. He has won multi-year grants from the National Institutes of Health, Burroughs-Wellcome Fund, Brain and Behavior Research Foundation, and Simons Foundation to further his research.

    Dr. Eshel has published articles on dopamine and motivation, the neuroscience of irritability, LGBTQ health, reward and punishment processing in depression, behavioral predictors of substance use among adolescents, and the mechanism of transcranial magnetic stimulation. His work has appeared in Nature, Science, Neuron, Nature Neuroscience, Annual Review of Neuroscience, JAMA, JAMA Psychiatry, Neuropsychopharmacology, Proceedings of the National Academy of Sciences, and Journal of Neuroscience. He is a co-inventor on a patent pending for a new class of drugs for addiction, and also the author of the book Learning: The Science Inside, a publication of the American Association for the Advancement of Science.

    He has delivered presentations on the neural circuits of motivated behavior, anger expression in patients with PTSD, how dopamine facilitates learning, and LGBTQ-related topics at departmental seminars in London, Zurich, and Tel Aviv, and at the meetings of the American College of Neuropsychopharmacology, Society of Biological Psychiatry, and Association of American Medical Colleges, among others. He is also an associate editor of the Journal of Gay and Lesbian Mental Health, and an ad-hoc reviewer for numerous publications including Nature, Science, JAMA Psychiatry, Biological Psychiatry, and Current Biology.

    Dr. Eshel has won honors for his scholarship and advocacy, including the Marshall Scholarship, the Outstanding Resident Award from the National Institute of Mental Health, the Science and SciLifeLab Grand Prize for Young Scientists, the Freedman Award (honorable mention) from the Brain and Behavior Research Foundation, the Polymath Award from Stanford's psychiatry department, and the National LGBT Health Achievement Award.

    He is a member of the American Psychiatric Association, American College of Neuropsychopharmacology, Society of Biological Psychiatry, Association of Gay & Lesbian Psychiatrists, Society for Neuroscience, and other professional associations. He is also an advocate for LGBTQ rights, recently serving as the chair of Stanford's LGBTQ+ Benefits Advocacy Committee.

    Prior to Stanford, Dr. Eshel trained and conducted research at the National Institutes of Health, Princeton University, the World Health Organization, University College London, and Harvard University.